Meinolf Karthaus, Jerome Schwingel, Hans Bauer, Nikolaus Ansorge, Gleb Barmashenko, Christof Burkart, Thomas Jens Ettrich, Anke Gerhardt, Sabine Hoefling, Lutz Jacobasch, Michael Koenigsmann, Sebastian Räth, Markos Schulte, Nadine Schulte, Andreas Schwarzer, Gabriele Margareta Siegler, Dirk Waldschmidt, Manfred P. Lutz. "Second-line therapy with Nal-IRI/5-FU/FA after failure of gemcitabine/nab-paclitaxel in advanced pancreatic cancer (PC): Predictive role of 1st-line therapy (PREDICT) and impact of quality of life (QoL).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.707